Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression.
about
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive DisorderTowards a personalized treatment in depression: endocannabinoids, inflammation and stress responseMonitoring candidate gene expression variations before, during and after a first major depressive episode in a 51-year-old man.The role of stress in absenteeism: cortisol responsiveness among patients on long-term sick leave.Placental FKBP5 genetic and epigenetic variation is associated with infant neurobehavioral outcomes in the RICHS cohortRecent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor.Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotypeTranscriptomic analysis of the effects of a fish oil enriched diet on murine brains.HPA axis genetic variation, pubertal status, and sex interact to predict amygdala and hippocampus responses to negative emotional faces in school-age childrenDepletion of FKBP51 in female mice shapes HPA axis activity.Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controlsHypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder.RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response.Examining gene-environment interactions in comorbid depressive and disruptive behavior disorders using a Bayesian approach.HIV-1 proteins accelerate HPA axis habituation in female rats.FKBP5 variation is associated with the acute and chronic effects of nicotineCross-cultural gene- environment interactions in depression, post-traumatic stress disorder, and the cortisol awakening response: FKBP5 polymorphisms and childhood trauma in South Asia.Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational ImplicationsGlucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression.Early-Life Adversity Interacts with FKBP5 Genotypes: Altered Working Memory and Cardiac Stress Reactivity in the Oklahoma Family Health Patterns ProjectChildhood maltreatment and methylation of FK506 binding protein 5 gene (FKBP5)Accumulation of cytoplasmic glucocorticoid receptor is related to elevation of FKBP5 in lymphocytes of depressed patients.Exploring epigenetic regulation of fear memory and biomarkers associated with post-traumatic stress disorderChronic corticosterone-mediated dysregulation of microRNA network in prefrontal cortex of rats: relevance to depression pathophysiologyMind and body: how the health of the body impacts on neuropsychiatry.The Association of Neighborhood Gene-Environment Susceptibility with Cortisol and Blood Pressure in African-American Adults.Deletion of Neurotrophin Signaling through the Glucocorticoid Receptor Pathway Causes Tau Neuropathology.Single-Nucleotide Polymorphism of the FKBP5 Gene and Childhood Maltreatment as Predictors of Structural Changes in Brain Areas Involved in Emotional Processing in Depression.Neuroendocrinology of a Male-Specific Pattern for Depression Linked to Alcohol Use Disorder and Suicidal Behavior.Possible association between haplotypes of the FKBP5 gene and suicidal bipolar disorder, but not with melancholic depression and psychotic features, in the course of bipolar disorder.Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder.Genetic variants in the genes of the stress hormone signalling pathway and depressive symptoms during and after pregnancy.Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention.Antidepressants for neuro-regeneration: from depression to Alzheimer's disease.Gene expression: biomarker of antidepressant therapy?Gene-environment interactions at the FKBP5 locus: sensitive periods, mechanisms and pleiotropism.Childhood adversity and epigenetic regulation of glucocorticoid signaling genes: Associations in children and adults.Understanding epigenetic architecture of suicide neurobiology: A critical perspective.Psychiatric symptoms in adolescents: FKBP5 genotype--early life adversity interaction effects.
P2860
Q26747511-AAE127EB-A5AE-4F83-9C24-65B0EC4FE7FBQ26851511-39951486-88AB-4472-A97C-828EDEC6C1F5Q31153904-476F69F1-6960-4E58-8095-8394E38C68CFQ33560289-E9DCA51F-86E0-4445-9315-27977F536F0DQ34035506-8AAC2B6E-BFF6-4A95-B24C-04E23AD45F87Q34139598-147BA902-4263-44E1-A0B0-AA1C59A25B17Q35047668-4D5EDA15-B1FF-4CB7-AE36-77E8E5F4A33BQ35121792-C5A5DD53-7575-4E0D-8AF7-157C454DBEE8Q35122393-FCEAB3C8-415B-4BAF-A63A-19FF8A8A5375Q35156039-0FE5200F-1784-4CA7-8E19-B5F06BB2FE4CQ35158376-56E03F86-8575-42BD-9CD0-B66A51353249Q35178985-FC5D88A6-17FD-437D-BB7F-9B642638B502Q35203604-E736F946-F97C-4E79-AAD1-DF8E32C6FC4BQ35598795-F240FE17-B8F5-4C90-B662-BF889D1FDB99Q35908050-95D20CDF-895E-4DE1-A3FA-C57CCA480774Q35929125-5AB204D3-9A7D-4450-8347-F510E55A6E51Q36141175-BBAEF083-C05D-4409-9511-FA9E9D25849FQ36216559-19CFD3FB-397F-44EE-B964-75D9BA211CA7Q36366772-0E2FC088-F64D-4939-AA82-B175C2565947Q36852421-B3EE141E-D75E-41EF-91DD-B11345C36C17Q36906655-2F1CB310-E439-4CEE-A66E-05AC7607D0DEQ36911117-F9190A37-EAA7-4C77-A3A9-C17ABAF5FDD2Q36940000-368045C4-D5D3-45F2-868C-76BEE7E0B938Q36968757-2933B5EB-D6EA-49C5-A813-18E6A926E9E4Q37347670-C0702F7D-5DE7-451E-B472-D894F111EED8Q37399776-FDCC5449-0383-4BF7-8CA1-832DD73090D6Q37413164-6562A44D-FFEA-4F22-9F28-42EDE4F8CF00Q37416638-F9039027-B103-4B47-91DD-926BC4AE7E75Q37458225-10EF8F4D-7318-4F54-840E-F33016E2F3D8Q37550094-D11EAF50-00BA-4E3B-B07E-E67D3D9FA175Q37577766-B5A744B3-63CE-40A5-ABEF-DE5DAA9F24C6Q37642670-F59819D2-C9FB-456A-917D-5CA60964079DQ37679549-1D21F608-9CFF-4615-BAB6-29CAFFEC3DBCQ37705451-A0B41539-724F-4D58-AFD7-156F2814957DQ38152966-2382C234-C79C-4902-A241-277B9FD9D9B7Q38154917-800E85C0-0585-434E-9F01-D215FC009346Q38161940-04F67FB3-6D81-402C-A374-1E1B1F611048Q38806319-882439DF-6C34-4711-A3CC-C3B83A89A2AEQ39005702-371E8865-8D48-4FEE-8971-64C0847652BCQ39282240-1D095D4C-086F-4CE9-8D32-1F2B4CA12CD2
P2860
Genetic variation in FKBP5 associated with the extent of stress hormone dysregulation in major depression.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Genetic variation in FKBP5 ass ...... egulation in major depression.
@en
Genetic variation in FKBP5 ass ...... egulation in major depression.
@nl
type
label
Genetic variation in FKBP5 ass ...... egulation in major depression.
@en
Genetic variation in FKBP5 ass ...... egulation in major depression.
@nl
prefLabel
Genetic variation in FKBP5 ass ...... egulation in major depression.
@en
Genetic variation in FKBP5 ass ...... egulation in major depression.
@nl
P2093
P2860
P50
P356
P1476
Genetic variation in FKBP5 ass ...... egulation in major depression.
@en
P2093
P2860
P304
P356
10.1111/GBB.12026
P407
P577
2013-03-07T00:00:00Z